BridgeMD
Tests treatment safety and results for Ageing
Official title Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-related Functional Decline (ICOPE Trial.Fr)
ClinicalTrials.gov ID: NCT06676839
What this study is testing
- What it's testing
- The World Health Organization (WHO) has designed an integrated care program (ICOPE) aimed at maintaining the functions of elderly people to preserve their autonomy. It includes four steps (Screening, Comprehensive Assessment, Personalized Prevention and Care Plan, Follow-up).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Participants aged 65 years and older.
- Participants living independently at home (ADL = 6, except for an occasional urinary abnormality which will be accepted).
- Participants showing functional decline in at least 2 of the 6 functional domains of ICOPE (mobility, cognition, nutrition, vision, hearing, and...
- Participants affiliated with a social protection system.
You likely can't join if
- Participants who has already benefited from the ICOPE program or who has completed more than one isolated step 1
- Participants living in a dependent elderly care facility.
- Participants with a disability preventing them from reaching the trial examination center without assistance (such as dementia or significant...
- Participants with hearing, visual, or speech impairments preventing them from understanding instructions or communicating with study staff.
- Participants with a life-threatening illness with a prognosis of less than 5 years.
- Participants unable to provide informed written consent.
See the full eligibility criteria
- Participants aged 65 years and older.
- Participants living independently at home (ADL = 6, except for an occasional urinary abnormality which will be accepted).
- Participants showing functional decline in at least 2 of the 6 functional domains of ICOPE (mobility, cognition, nutrition, vision, hearing, and psychological well-being) identified using the ICOPE screening tool.
- Participants affiliated with a social protection system.
- Participants who has already benefited from the ICOPE program or who has completed more than one isolated step 1
- Participants living in a dependent elderly care facility.
- Participants with a disability preventing them from reaching the trial examination center without assistance (such as dementia or significant mobility impairment).
- Participants with hearing, visual, or speech impairments preventing them from understanding instructions or communicating with study staff.
- Participants with a life-threatening illness with a prognosis of less than 5 years.
- Participants unable to provide informed written consent.
- Participants under legal protection, guardianship, or trusteeship.
- Participants participating in another treatment research study.
- Participants in a relationship with a person participating in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Castres, France, France
- Perpignan, France, France
- Tarbes, France, France
- Toulouse, France, France
- Angers, France
- Limoges, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Castres, France, France; Perpignan, France, France; Tarbes, France, France; Toulouse, France, France; Angers, France; Limoges, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.